JAK inhibitors disrupt T cell-induced proinflammatory macrophage activation
Objectives Macrophage subsets, activated by T cells, are increasingly recognised to play a central role in rheumatoid arthritis (RA) pathogenesis. Janus kinase (JAK) inhibitors have proven beneficial clinical effects in RA. In this study, we investigated the effect of JAK inhibitors on the generatio...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/1/e002671.full |